Canadian study reveals one in four women with ADHD has attempted suicide ANI | Updated: Dec 22, 2020 22:28 IST
Toronto [Canada], December 22 (ANI): A nationally representative Canadian study reported that the lifetime prevalence of suicide attempts was much higher (24 per cent ) for women with Attention Deficit Hyperactive Disorder (ADHD) compared to those women who did not (3 per cent).
Men with ADHD were also more likely to have attempted suicide than those without the disorder. (9 per cent vs. 2 per cent ).
The study was published in the journal Archives of Suicide Research. ADHD casts a very long shadow. Even when we took into account history of mental illness, and the higher levels of poverty and early adversities that adults with ADHD often experience, those with ADHD still had 56 per cent higher odds of having attempted suicide than their peers without ADHD reported lead author Esme Fuller-Thomson, Professor at University of Toront
Date Time
Medicine by Design symposium highlights importance of convergence in regenerative medicine and human health
Researchers are poised to make unprecedented breakthroughs in human health thanks to advances in biomedical and computational sciences that have driven critical tools and technologies such as genetic engineering, synthetic biology, and artificial intelligence.
That’s the message Dr. Victor Dzau, president of the U.S. National Academy of Medicine, delivered to Medicine by Design’s fifth annual symposium on Dec. 7 and 8.
The virtual event, which attracted more than 500 registrants from across North America, focused on the theme of better science through convergence – the integration of approaches from engineering, science, medicine and other fields to expand knowledge and spark innovation.
Ontario has had seven straight days of more than 2,000 cases a day. Modeling shows that could more than double in January. Health officials earlier said a four to six-week hard lockdown could significantly stop the spread of COVID-19.
Toronto, Canada’s largest city, had already closed restaurants for indoor dining but schools remained open. All high schools in Ontario will now be closed for in-person learning until January 25. Elementary schools will be closed until January 11.
After COVID-19 cases surged in the spring, Canada flattened the epidemic curve with a lockdown. But as in other countries, COVID fatigue set in, restrictions were relaxed and a second wave was unleashed.
Date Time
How virtual rehab is bridging pandemic gaps in patient care and research A physiotherapist leads chair-based exercises for virtual rehabilitation at West Park Healthcare Centre (photo courtesy Temerty Faculty of Medicine)
What if you experienced a stroke and needed physical and cognitive therapy – but hospitals and clinics had suspended these vital rehabilitation services due to the COVID-19 pandemic?
Enter Mark Bayley of the University of Toronto’s Temerty Faculty of Medicine, whose work focuses on brain injury, stroke and multiple sclerosis.
“After COVID-19 hit, people weren’t able to get the usual outpatient rehab to optimize their recovery and health,” says Bayley, an associate professor in the division of physical medicine and rehabilitation in the department of medicine.
TORONTO A Saskatchewan-developed COVID-19 vaccine candidate is the latest to be approved for human trials in Canada, and could be ready by the end of 2021, its backers say. The vaccine candidate is one of two being developed by the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan. VIDO reported Tuesday that it has received authorization from Health Canada to begin a Phase 1 clinical trial through the Canadian Center for Vaccinology in Halifax. Participants will be recruited shortly, VIDO said, with vaccinations starting in January. Volker Gerdts, director and CEO of VIDO, said in a statement that if the three-phase trials prove successful, VIDO s vaccine candidate could be ready for use by late 2021.